This article is more than 5 years old. Information may no longer be current.
FDA approves daily disposable multifocal contact lens
Click Here to Manage Email Alerts
PHILADELPHIA – Bausch + Lomb announced here at Optometry’s Meeting that the U.S. Food and Drug Administration granted marketing clearance for the company’s Biotrue OneDay for Presbyopia daily disposable multifocal.
Bausch + Lomb’s director of medical strategy for U.S. Vision Care, Benjamin S. Chudner, OD, FAAO, told Primary Care Optometry News that this lens, made of nesofilcon A, meets the oxygen level the open eye needs for health, mimicking the lipid layer of tears.
This multifocal is based on the PureVision2 multifocal concept, he said.
The lens is available from -9 D to + 6 D in 0.25-D steps, with low adds coming in 2014 and high adds in 2015, Chudner said. It is being launched to a limited number of accounts now, expanding later this year and again in 2015.
Chudner also said that Bausch + Lomb is bringing back the emulsion system, Soothe XP, with the same active ingredient, Restoryl.
“It’s cloudy initially, but when you blink, it realigns to a lipid layer and water/aqueous layer,” he said.
Chudner also shared the availability of the EyeMask, a joint venture with TheraPearl, a company that distributes hot and cold packs for drug-free pain relief. The mask can be used as cold therapy for puffiness or hot therapy for meibomian gland disease, he said. – by Nancy Hemphill, ELS